UPDATE 1-Once-daily Schering hepatitis C drug shows promise | Reuters

"An experimental newer treatment for hepatitis C being developed by Schering-Plough Corp showed impressive effectiveness and was well tolerated in an ongoing mid-stage study, researchers said on Monday, citing interim data."